The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / When Interstitial Lung Disease and Connective Tissue Disorder Intersect in Rheumatology Patients

When Interstitial Lung Disease and Connective Tissue Disorder Intersect in Rheumatology Patients

February 15, 2017 • By Larry Beresford

  • Tweet
  • Email
Print-Friendly Version / Save PDF

“A diagnosis of ILD is a real blow to patients and families. What they want and need is information about the disease, its treatment and expected course,” Dr. Collard said. “Once they are past the shock of the initial diagnosis, they want information about how to live with the disease.”

You Might Also Like
  • Tackle Tricky Lung Complications in Connective Tissue Disease
  • Cyclophosphamide for Connective Tissue Disease-Associated Interstitial Lung Disease
  • What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)
Explore This Issue
February 2017

A palliative care approach can be helpful from the point of diagnosis, with an evaluation for hospice eligibility when the disease becomes less manageable. Palliative care offers a range of support with symptoms, fears, financial burdens and spiritual or existential distress.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Lung transplant is the ultimate treatment for severe incurable lung disease, said Jeffrey Golden, MD, associate medical director of the Lung Transplantation Program at UCSF. The number of lung transplants performed annually worldwide is now up to 4,000, and more than half of them have been for CTD-ILD patients, he said. “You want people on the lung allocation list who have the best chance to get a transplant, but who aren’t so sick that it’s futile. If you have somebody with a diagnosis of ILD who could be a candidate, they should contact a transplant program for an informational evaluation session.”


Larry Beresford is a freelance medical journalist in Oakland, Calif.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Fischer A, Antoniou KM, Brown KK, et al. for the ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD. An official European Respiratory Society/American Thoracic Society research statement: Interstitial pneumonia with autoimmune features. Eur Respir J. 2015 Oct;46(4):976–987.
  2. Hagmeyer L, Theegarten D, Wohlschläger J, et al. The role of transbronchial cryobiopsy and surgical lung biopsy in the diagnostic algorithm of interstitial lung disease. C Clin Respir J. 2016 Sep;10(5):589–595.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Education & Training, Meeting Reports Tagged With: Clinical, connective tissue disorder, Diagnosis, interstitial lung disorder, patient care, Research, Rheumatic Disease, rheumatologist, rheumatology, therapy, TreatmentIssue: February 2017

You Might Also Like:
  • Tackle Tricky Lung Complications in Connective Tissue Disease
  • Cyclophosphamide for Connective Tissue Disease-Associated Interstitial Lung Disease
  • What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)
  • Summit on Connective Tissue Disease-Associated ILD Fosters Interdisciplinary Dialogue

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)